TriSalus Life Sciences, Inc. (TLSI)
3.57
-0.06
(-1.65%)
USD |
NASDAQ |
Oct 19, 15:28
TriSalus Life Sciences Market Cap : 219.45M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 223.13M |
| October 15, 2026 | 239.73M |
| October 14, 2026 | 239.73M |
| October 13, 2026 | 245.88M |
| October 12, 2026 | 254.48M |
| October 09, 2026 | 249.57M |
| October 08, 2026 | 253.87M |
| October 07, 2026 | 261.25M |
| October 06, 2026 | 262.48M |
| October 05, 2026 | 269.24M |
| October 02, 2026 | 265.55M |
| October 01, 2026 | 255.10M |
| September 30, 2026 | 264.93M |
| September 29, 2026 | 261.25M |
| September 28, 2026 | 269.85M |
| September 25, 2026 | 266.78M |
| September 24, 2026 | 283.37M |
| September 23, 2026 | 307.35M |
| September 22, 2026 | 303.05M |
| September 21, 2026 | 306.12M |
| September 18, 2026 | 313.50M |
| September 17, 2026 | 301.20M |
| September 16, 2026 | 303.05M |
| September 15, 2026 | 293.82M |
| September 14, 2026 | 293.21M |
| Date | Value |
|---|---|
| September 11, 2026 | 286.76M |
| September 10, 2026 | 288.91M |
| September 09, 2026 | 292.60M |
| September 08, 2026 | 290.75M |
| September 04, 2026 | 307.35M |
| September 03, 2026 | 306.12M |
| September 02, 2026 | 315.95M |
| September 01, 2026 | 317.80M |
| August 31, 2026 | 304.27M |
| August 28, 2026 | 296.90M |
| August 27, 2026 | 303.05M |
| August 26, 2026 | 303.05M |
| August 25, 2026 | 309.19M |
| August 24, 2026 | 314.11M |
| August 21, 2026 | 323.94M |
| August 20, 2026 | 321.49M |
| August 19, 2026 | 337.47M |
| August 18, 2026 | 331.94M |
| August 17, 2026 | 323.94M |
| August 14, 2026 | 323.94M |
| August 13, 2026 | 346.07M |
| August 12, 2026 | 350.99M |
| August 11, 2026 | 352.84M |
| August 10, 2026 | 343.00M |
| August 07, 2026 | 344.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.389B |
| Alnylam Pharmaceuticals, Inc. | 31.31B |
| Anika Therapeutics, Inc. | 271.67M |
| Savara, Inc. | 957.16M |
| Vericel Corp. | 2.070B |
Market Cap Related Metrics
| PS Ratio | 3.970 |
| PEG Ratio | -0.2783 |
| Price to Book Value | 33.50 |
| Price | 3.57 |
| Earnings Yield | -36.27% |
| PEGY Ratio | -0.2783 |